SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
OHI

Omega Healthcare Investors Inc (New York Stock Exchange:OHI)

US · Delayed Price · Currency is USD
Also listed: 0KBL.LReal Estate · REIT - Healthcare Facilities
46.90+0.67 (+1.44%)
 
Market cap
$14.2B
Health Score
Analyst consensus
Listed since
Aug 7, 1992
Insider Score
––Not scored
OHI Insider Score

Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

Financial Health Score
Sound
From OHI’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20

Keeps a healthy share of every dollar it sells.

Revenue
$1.29B
Net income
$858.3M
Net margin
66.4%
Leverage6 / 20

Heavily indebted for what it earns.

Total debt
$4.02B
Cash
$39.0M
Net debt / EBITDA
2.75x
Liquidity5 / 20

Owes more within a year than it holds to pay it.

Current assets
$315.1M
Current liabilities
$347.9M
Current ratio
0.91
Cash generation20 / 20

The business funds itself from operations.

Operating cash flow
$890.6M
Free cash flow
$903.3M
FCF margin
69.9%
Dilution & runway18 / 20

Not funding itself by issuing shares.

Shares outstanding
298.8M
Share growth (1y)
2.6%

Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.

OHI Income Statement

Fiscal PeriodQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Revenue335.63 M322.95 M321.82 M311.59 M282.51 M276.79 M
Revenue Growth (YoY)18.80 %16.68 %15.22 %12.88 %11.78 %13.76 %
Cost of Revenue179.88 M9.01 M169.87 M3.50 M3.25 M3.31 M
Gross Profit155.75 M313.94 M151.95 M308.09 M279.25 M273.47 M
SG&A Expense14.38 M26.02 M0.0023.78 M23.84 M32.06 M
R&D Expense0.000.000.000.000.000.00
Operating Expenses-32.82 M106.87 M-52.36 M101.98 M99.58 M117.02 M
Operating Income188.57 M207.08 M204.31 M206.10 M179.68 M156.45 M
Pretax Income384.29 M163.68 M174.10 M189.44 M145.01 M115.67 M
Tax Provision4.62 M5.11 M2.13 M4.48 M4.53 M3.61 M
Net Income362.82 M151.05 M164.72 M179.72 M136.60 M109.03 M
EPS (Basic)1.210.470.580.630.460.34
EPS (Diluted)1.190.470.550.590.460.33
Shares Outstanding298.85 M297.05 M296.37 M295.83 M291.19 M283.01 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.